Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281:8–27. https://doi.org/10.1111/imr.12621.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van de Veerdonk FL, Netea MG. New insights in the immunobiology of IL-1 family members. Front Immunol. 2013;4:167. https://doi.org/10.3389/fimmu.2013.00167.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu D, Mu R, Wei X. The roles of IL-1 family cytokines in the pathogenesis of systemic sclerosis. Front Immunol. 2019;10:2025. https://doi.org/10.3389/fimmu.2019.02025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsang MS, Sun X, Wong CK. The role of newe IL-1 family members (IL-36 and IL-38) in atopic dermatitis, allergic asthma, and allergic rhinitis. Curr Allergy Asthma Rep. 2020;20:40. https://doi.org/10.1007/s1182-020-00937-1.

Article  CAS  PubMed  Google Scholar 

Boutet MA, Nerviani A, Pitzalis C. IL-36, IL-37, and IL-38 cytokines in skin and joint inflammation: a comprehensive review of their therapeutic potential. Int J Mol Sci. 2019;20:1257. https://doi.org/10.3390/ijms20061257.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madonna S, Girolomoni G, Dinarello CA, Albanesi C. The significance of IL-36 hyperactivation and IL-36R targeting in psoriasis. Int J Mol Sci. 2019;20:3318. https://doi.org/10.3390/ijms20133318.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Towne JE, Renshaw BR, Douangpanya J, Lipsky BP, Shen M, Gabel CA, Sims JE. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity. J Biol Chem. 2011;286:42594–602. https://doi.org/10.1074/jbc.M111.267922.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henry CM, Sullivan GP, Clancy DM, Afonina IS, Kulms D, Martin SJ. Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines. Cell Rep. 2016;14:708–22. https://doi.org/10.1016/j.celrep.2015.12.072.

Article  CAS  PubMed  Google Scholar 

Macleod T, Doble R, McGonagle D, Wasson CW, Alase A, Stacey M, Wittmann M. Neutrophil elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 receptor antagonist. Sci Rep. 2016;6:24880. https://doi.org/10.1038/srep24880.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clancy DM, Henry CM, Sullivan GP, Martin SJ. Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines. FEBS J. 2017;284:1712–25. https://doi.org/10.1111/febs.14075.

Article  CAS  PubMed  Google Scholar 

Clancy DM, Sullivan GP, Moran HBT, Henry CM, Reeves EP, McElvaney NG, et al. Extracellular neutrophil proteases are efficient regulators of IL-1, IL-33, and IL-36 cytokine activity but poor effectors of microbial killing. Cell Rep. 2018;22:2937–50. https://doi.org/10.1016/j.celrep.2018.02.062.

Article  CAS  PubMed  Google Scholar 

Guo J, Tu J, Hu Y, Song G, Yin Z. Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis. Drug Des Devel Ther. 2019;13:581–8. https://doi.org/10.2147/DDDT.S194765.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnston A, Xing X, Wolterink L, Barnes DH, Yin Z, Reingold L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140:109–20. https://doi.org/10.1016/j.jaci.2016.08.056.

Article  CAS  PubMed  Google Scholar 

Gresnigt MS, van de Veerdonk FL. Biology of IL-36 cytokines and their role in disease. Semin Immunol. 2013;25:458–65. https://doi.org/10.1016/j.smim.2013.11.003.

Article  CAS  PubMed  Google Scholar 

Boutet MA, Bart G, Penhoat M, Amiaud J, Brulin B, Charrier C, et al. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn’s disease. Clin Exp Immunol. 2016;184:159–73. https://doi.org/10.1111/cei.12761.

Article  CAS  PubMed  Google Scholar 

Dyring-Andersen B, Løvendorf MB, Coscia F, Santos A, Møller LBP, Colaço AR, et al. Spatially and cell-type resolved quantitative proteomic atlas of healthy human skin. Nat Commun. 2020;11:5587. https://doi.org/10.1038/s41467-020-19383-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Albanesi C, Madonna S, Gisondi P, Girolomoni G. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis. Front Immunol. 2018;9:1549. https://doi.org/10.3389/fimmu.2018.01549.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walsh PT, Fallon PG. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases. Ann N Y Acad Sci. 2018;1417:23–34. https://doi.org/10.1111/nyas.13280.

Article  CAS  PubMed  Google Scholar 

Murrieta-Coxca JM, Rodríguez-Martínez S, Cancino-Diaz ME, Markert UR, Favaro RR, Morales-Prieto DM. IL-36 cytokines: regulators of inflammatory responses and their emerging role in immunology of reproduction. Int J Mol Sci. 2019;20:1649. https://doi.org/10.3390/ijms20071649.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van de Veerdonk FL, Stoeckman AK, Wu G, Boeckermann AN, Azam T, Netea MG, et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci USA. 2012;109:3001–5. https://doi.org/10.1073/pnas.1121534109.

Article  PubMed  PubMed Central  Google Scholar 

Calabrese L, Fiocco Z, Satoh TK, Peris K, French LE. Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases. Br J Dermatol. 2022;186:925–41. https://doi.org/10.1111/bjd.20975.

Article  CAS  PubMed  Google Scholar 

Foster AM, Baliwag J, Chen CS, Guzman AM, Stoll SW, Gudjonsson JE, et al. IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J Immunol. 2014;192:6053–61. https://doi.org/10.4049/jimmunol.1301481.

Article  CAS  PubMed  Google Scholar 

Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, Rodriguez E, et al. IL-36R ligands are potent regulators of dendritic and T cells. Blood. 2011;118:5813–23. https://doi.org/10.1182/blood-2011-05-356873.

Article  CAS  PubMed  Google Scholar 

Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O’Toole M, et al. Inter-regulation of Th-17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol. 2011;131:2428–37. https://doi.org/10.1038/jid.2011.234.

Article  CAS  PubMed  Google Scholar 

Li N, Yamasaki K, Saito R, Fukushi-Takahashi S, Shimada-Omori R, Asano M, et al. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes. J Immunol. 2014;193:5140–8. https://doi.org/10.4049/jimmunol.1302574.

Article  CAS  PubMed  Google Scholar 

Gabay C, Towne JE. Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions. J Leukoc Biol. 2015;97:645–52. https://doi.org/10.1189/jlb.3RI1014-495R.

Article  CAS  PubMed  Google Scholar 

Giannoudaki E, Stefanska AM, Lawler H, Leon G, Hernandez Santana YE, Hassan N, et al. SIGIRR negatively regulates IL-36-driven psoriasiform inflammation and neutrophil infiltration in the skin. J Immunol. 2021;207:651–60. https://doi.org/10.4049/jimmunol.2100237.

Article  CAS  PubMed  Google Scholar 

Bou-Dargham MJ, Khamis ZI, Cognetta AB, Sang QA. The role of interleukin-1 in inflammatory and malignant human skin diseases and the rationale for targeting interleukin-1 alpha. Med Res Rev. 2017;37:180–216. https://doi.org/10.1002/med.21406.

Article  CAS  PubMed  Google Scholar 

Bridgewood C, Fearnley GW, Berekmeri A, Laws P, Macleod T, Ponnambalam S, et al. IL-36γ is a strong inducer of IL-23 in psoriatic cells and activates angiogenesis. Front Immunol. 2018;9:200. https://doi.org/10.3389/fimmu.2018.00200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buhl AL, Wenzel J. Interleukin-36 in infectious and inflammatory skin diseases. Front Immunol. 2019;10:1162. https://doi.org/10.3389/fimmu.2019.01162.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akiyama M, Takeichi T, McGrath JA, Sugiura K. Autoinflammatory keratinization diseases. J Allergy Clin Immunol. 2017;140:1545–7. https://doi.org/10.1016/j.jaci.2017.05.019.

Article  PubMed  Google Scholar 

Akiyama M, Takeichi T, McGrath JA, Sugiura K. Autoinflammatory keratinization diseases: an emerging concept encompassing various inflammatory keratinization disorders of the skin. J Dermatol Sci. 2018;90:105–11. https://doi.org/10.1016/j.jdermsci.2018.01.012.

Article  CAS  PubMed  Google Scholar 

Akiyama M. Pustular psoriasis as an autoinflammatory keratinization disease (AiKD): genetic predisposing factors and promising therapeutic targets. J Dermatol Sci. 2022;105:11–7. https://doi.org/10.1016/j.jdermsci.2021.11.009.

Article  CAS  PubMed